Alexander M.M. Eggermont

Board of the Comprehensive Cancer Center Munich (CCCM), Technical University Munich & Ludwig Maximiliaan University Munich,  Munich, Germany.
Chief Scientific Officer Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands  Prof Clinical &Translational Immunotherapy, University Medical Center Utrecht, Netherlands.
Coordinator Comprehensive Cancer Center Program Deutsche KrebsHilfe, Germany  & Strategic Advisor @ DKFZ-NCT Heidelberg for National Center for Tumors Program, Germany.
Past Director General, Gustave Roussy Cancer Campus Grand Paris, France (2010-2019) & Emeritus Professor Oncology, University Paris-Saclay, France (2012-2021).
Emeritus Professor International Networking Cancer Research, ErasmusMC, Rotterdam, NL  Emeritus Professor Surgical Oncology Erasmus University Rotterdam, NL.
Honorary Professor Surgical Oncology, Catholic University Leuven, Belgium.
Fellow of USA NIH-NCI Surgery Branch (Steve Rosenberg) (85-86) PhD1987 TumorImmunology.

International (current & past) scientific societal positions

• President European Academy of Cancer Sciences (2010-2019), Executive board (2019-now)
• President Cancer Core Europe 2014-2019
• ECCO President European CanCer Organization 2009-2011
• EORTC President 2006-2009, Exec Board 1998-2012, Chairman Melanoma Group(1994-2000)
• ASCO: Board of Directors of ASCO (2008-2010; Surgery Chair) and JCO Editorial Board
• AACR: Deputy Editor of Clinical Cancer Research 2001-2009
• ESMO: Executive Board:  2014-2018
• CRUK: Board of Trustees/Strategic Research Committee 2016-2019
• DFG: Wissenschaftsrat, Germany: 2017-2020
• DKH (Deutsche Krebshilfe) (Since 2007-Now) President International Jury CCC-Program
• European Journal of Cancer: Editor-in-Chief since 01-01-2011

Professional awards (selection): Joseph Maisin Chair in Oncology at Catholic University of Louvain in Belgium (2001); ASCO Statesman Award (2010); Michiel Van Vloten Award of the Dutch Surgical Society (2016); John Wayne Award of Clinical Research of Society Surgical Oncology (2018); Doctorate Honoris Causa (University Essen, Germany) (2018); Honorary Chair KAZIOR (Kazakh Institute of Oncology and Radiotherapy)(2019); Deutsche Krebshilfe Cancer Award (2019)

Specialties & Scientific Output: Clinical: immunotherapy, melanoma, sarcoma,drug development. Basic/Translational: tumor immunology, animal models. Scientific Output: >1000 publications; 36 PhD theses @ ErasmusMC:  H-index/citations: 113, >61000 citations (Web of Science),  HI:115, >66000 (Scopus); HI:128, >80000 (Research Gate);  HI:134, >93000 citations (Google Scholar)

Societal Awards:       Légion d’Honneur, France (2015)